Financials
- Market Capitalization 2.29 B
- Employee 293
- Founded 2017
- CEO N/A
- Website www.harmonybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00WBPG4C2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
13.81
Rapporto prezzo/fatturato
2.52
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1905 | OCUL Ocular Therapeutix, Inc. - Common Stock | 10.55 USD | -2.50% | -6.55% | +23.97% | -8.26% | 2.32 B USD | ||
| 1913 | MESO Mesoblast Limited - American Depositary Shares | 17.56 USD | -3.41% | +3.48% | +22.45% | +23.49% | 2.28 B USD | ||
| 1933 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.34 USD | -2.58% | -2.58% | -6.15% | -37.23% | 2.24 B USD | ||
| 1940 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.50 USD | -0.96% | -1.77% | +10.71% | +139.47% | 2.22 B USD |